InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（15 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
15
T+90 胜率
0%
T+90 平均收益
-43.4%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Shah Gaurav, 首席执行官. Insider active across 1 company, notably Rocket Pharmaceuticals, INC.. Aggregated, 26 filings have been recorded. Split: 2 buys · 15 sells. Total volume traded: €1.9m. Activity tracked since 7 February 2022. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Shah Gaurav
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
2,293 股@ US$3.381Common StockSEC:0001140361-26-033913:0
2,837 股@ US$3.3810.0025% mcap0.4% 占其流量Common StockSEC:0001140361-26-033417:0
2,728 股@ US$3.6060.0024% mcap1.2% 占其流量Common StockSEC:0001140361-26-021315:0
5,990 股@ US$3.3380.9% 占其流量Common StockSEC:0001140361-26-006326:0
12,279 股@ US$3.3121.8% 占其流量Common StockSEC:0001140361-26-006043:0
286,028 股0Common StockSEC:0001140361-26-005412:0
6,276 股@ US$2.9830.9% 占其流量Common StockSEC:0001140361-25-042855:0
2,234 股@ US$3.050.3% 占其流量Common StockSEC:0001140361-25-032089:0
2,253 股@ US$6.4460.6% 占其流量Common StockSEC:0001140361-25-020160:0
3,621 股@ US$6.5281.0% 占其流量Common StockSEC:0001140361-25-019899:0
20,000 股@ US$5.084.1% 占其流量Common StockSEC:0001140361-25-013804:0
标准退出：2025年7月9日 (T+90)
16,303 股@ US$10.587.5% 占其流量Common StockSEC:0001140361-25-005844:0
81,655 股0Common StockSEC:0001140361-25-004296:0
11,091 股@ US$13.0546.2% 占其流量Common StockSEC:0001140361-24-047755:0
9,650 股@ US$18.5047.4% 占其流量Common StockSEC:0001140361-24-037932:0
7,979 股0Common StockSEC:0001140361-24-026878:0
20,272 股@ US$29.83825.5% 占其流量Common StockSEC:0001140361-24-008886:0
46,828 股0Common StockSEC:0001140361-24-008359:0
7,979 股0Common StockSEC:0001140361-23-053709:0
4,767 股@ US$15.4713.1% 占其流量Common StockSEC:0001140361-23-040694:0
7,979 股0Common StockSEC:0001140361-23-039901:0
4,122 股@ US$21.3753.7% 占其流量Common StockSEC:0001140361-23-025742:0
7,979 股0Common StockSEC:0001140361-23-025133:0
12,194 股@ US$19.069.9% 占其流量Common StockSEC:0001140361-23-008102:0
31,440 股0Common StockSEC:0001140361-23-008098:0
26 条申报中的 25 条
About Shah Gaurav
Shah Gaurav is Directeur Général and CEO of Rocket Pharmaceuticals, INC. He has 24 filings in total, and across the 24 sampled filings between 2022-02-08 and 2026-05-14, purchases amount to EUR 423298 and sales to EUR 1502399, with cession as the dominant transaction type.
